RecruitingNCT07059962

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

Sensor-based Congestion Alert for Events in Peritoneal Dialysis (SCALE-PD)


Sponsor

Bodyport Inc.

Enrollment

125 participants

Start Date

Sep 9, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a sensor-based smart scale that monitors fluid retention can help detect dangerous fluid buildup early in patients receiving peritoneal dialysis (a type of home kidney dialysis). Fluid overload is a common and serious complication in dialysis patients, and early alerts may prevent hospitalizations. **You may be eligible if...** - You are 21 years of age or older - You are on automated peritoneal dialysis for end-stage kidney disease (ESKD) - You can stand on two feet unassisted - You are managed on the Vantive Sharesource remote monitoring platform - You can speak and read English, or have a caregiver who can assist **You may NOT be eligible if...** - You are under 21 years of age - You are on hemodialysis (a different type of dialysis) rather than peritoneal dialysis - You cannot stand unsupported on a scale - You are not enrolled in the required remote monitoring system - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBodyport Cardiac Scale

The Bodyport Cardiac Scale captures several physiological signals, which are used to derive multiple biomarkers that reflect a user's hemodynamic and fluid status.


Locations(4)

Desert Cities Dialysis

Victorville, California, United States

Southeastern Clinical Research Institute

Augusta, Georgia, United States

Northwestern University

Chicago, Illinois, United States

Seven Oaks General Hospital

Winnipeg, Manitoba, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07059962


Related Trials